A-L-A-L

CAS No. 84676-48-2

A-L-A-L( ——— )

Catalog No. M41812 CAS No. 84676-48-2

Ala-Leu-Ala-Leu is a peptide. Ala-Leu-Ala-Leu can be used for the research of experiment research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    A-L-A-L
  • Note
    Research use only, not for human use.
  • Brief Description
    Ala-Leu-Ala-Leu is a peptide. Ala-Leu-Ala-Leu can be used for the research of experiment research.
  • Description
    Ala-Leu-Ala-Leu is a peptide. Ala-Leu-Ala-Leu can be used for the research of experiment research.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    84676-48-2
  • Formula Weight
    386.5
  • Molecular Formula
    C18H34N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Irtaza Hassan, et al. Effect of the Hydration Shell on the Carbonyl Vibration in the Ala-Leu-Ala-Leu Peptide. Molecules. 2021 Apr 8;26(8):2148.?
molnova catalog
related products
  • CKS-17

    CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions.

  • Sodium citrate

    Sodium citrate (Natrocitral) is the sodium salt of citric acid.Citric acid trisodium induces apoptosis and cell cycle arrest at G2/M phase and S phase.

  • [Pyr3]-Amyloid β-Pro...

    Amyloid β-Protein (3-42) is the precursor of Pyr peptide. Pyroglutamate-modified Aβ (pEAβ) (3-42) is the core of the amyloid template block in Alzheimer's disease. pEAβ(3-42) accelerated the aggregation of Aβ(1-42), while Aβ(1-42) significantly slowed the primary and secondary nucleation of pEAβ(3-42).